ECP 2023 Final Programme

E-Posters 115 ECP 2023 Dublin E-PS-02 022 Spontaneous regression of breast carcino- ma. Presentation of three cases with immunohistochemical study of TILs Alicia Córdoba, Spain R. Beloqui, I. Amat, I. Fernandez, M. Mercado, C. Cerezo, D. Guerrero 023 Syringomatous tumour: case report Ayse Das Cerci, Turkey T. Toyran, M. Ergin, S. Zorludemir 024 Benign Müllerian inclusion in the axillary lymph node of a patient with breast carcinoma: a case report Sule Kevser Dursun, Turkey T. Soylemez Akkurt 025 Male breast carcinoma in a symptomatic breast unit, a ten year retrospective review Robert Farrell, Ireland A. O’Shea, M. Staunton 026 Computer-aided quantitative analysis as second opinion in the assessment of low HER2 IHC score in breast cancer – a pilot evaluation Yael Glickman, Israel S. Zilber, Y. Arbel, Y. Sufrin, B. Benbenishti, Y. Sherman 027 Incidence of atypical lesions in routine breast reductions warrants assessment of the feasibility of orientation and inking each specimen Tahmina Gul, Ireland M. Leader 028 Rare presentation of medullary thyroid carcinoma with bilateral breast metastasis: a case report Eylul Gun, United Kingdom O. Layth Qassid 029 In hormone receptor-positive breast cancers (estrogen receptor and/or progesterone receptor positive and HER2 negative) can the Ki-67 proliferation index in the tru-cut biopsy guide us for the neoadjuvant treatment response? Ismail Guzelis, Turkey B. Bolat Kucukzeybek, Y. Kucukzeybek 030 Idiopathic granulomatous mastitis (IGM) – a diagnostic challenge Grace Hennessy, Ireland K. Ryan, E. Houlihan, J. Mannion, B. Dunne, B. O’Connell, E. Connolly 031 Breast ductal carcinoma in situ diagnosed by stereotactic vacuum-assisted biopsy has favourable pathologic features and a lower upstage rate Chung-Yen Huang, Taiwan C. Lee, C. Lin, R. Chang, P. Liao, P. Lin, Y. Lee 032 Comparison of two sentinel node imaging methods magtrace and scintigraphy Pavel Hurník, Czech Republic J. Strakos, J. Palica, Z. Vavrova, R. Ondrussek, F. Fakhouri, P. Vazan, P. Delongová, V. Zidlik, D. Ziak 033 Metastatic uterine leiomyosarcoma presenting as a symptomatic breast lump: a case report Nermina Ibiševic, Bosnia and Herzegovina A. Humackic, Z. Guzin, K. Tomic, B. Lukic, S. Vranic 034 Prognostic implications of histopathological evaluation in post-neoadjuvant chemother- apy breast cancer patients: our experience Martina Iuzzolino, Italy C. De Carlo, D. Gentile, A. Sagona, E. Barbieri, S. Di Maria Grimaldi, R. Trimboli, D. Bernardi, S. Darwish, C. Tinterri, L. Terracciano, B. Fernandes 035 HER2 expression is sensitive to intratu- moural hypoxia in HER2-low invasive breast carcinoma Peter Juhasz, Hungary G. Mehes 037 Not all breast adenoid cystic carcinomas are created equal Mouna Khmou, Morocco